4-Nitrochalcone (2-(4-Nitrobenzylidene)acetophenone) inhibits theproteasome, inhibitsNF-κBactivity induced by TNFα[1].
References:
[1].Claudia Martins Galindo, et al. 4-Nitrochalcone as a potential drug in non-clinical breast cancer studies. Chem Biol Interact. 2024 Jan 5:387:110790.
















